CLINICAL_TRIALS
trial_result
· 2016-08-31
Clinical Trial Update: Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP) [Phase 3]
Summary
The Phase 3 HARMONY CTP trial evaluating pitolisant for narcolepsy with cataplexy and excessive daytime sleepiness has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bioprojet | Conditions: Narcolepsy With Cataplexy, Excessive Daytime Sleepiness | Phase 3 | Status: COMPLETED